2WF2

Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1H,6H-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2009-05-19	Initial release
1.1	2011-05-08		Version format compliance
1.2	2011-07-13		Version format compliance
1.3	2019-03-06		Data collection, Experimental preparation, Other	exptl_crystal_grow, pdbx_database_proc, pdbx_database_status
1.4	2019-05-15		Data collection, Experimental preparation	exptl_crystal_grow
1.5	2024-11-06		Data collection, Database references, Derived calculations, Other, Structure summary	chem_comp_atom, chem_comp_bond, database_2, pdbx_database_status, pdbx_entry_details, pdbx_modification_feature, struct_site	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.